Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach
Authors:
Open Access
- 23 September 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (9) , e0134971
Abstract
Despite a significant prognostic impact, little is known about disturbances in glucose metabolism among kidney transplant candidates. We assess the prevalence of diabetes mellitus (DM) and prediabetes on kidney transplant waiting list, its underlying pathophysiology and propose an approach for individual risk stratification. All patients on active kidney transplant waiting list of a large European university hospital transplant center were metabolically phenotyped. Of 138 patients, 76 (55%) had disturbances in glucose metabolism. 22% of patients had known DM, 3% were newly diagnosed. 30% were detected to have prediabetes. Insulin sensitivity and-secretion indices allowed for identification of underlying pathophysiology and risk factors. Age independently affected insulin secretion, resulting in a relative risk for prediabetes of 2.95 (95%CI 1.38–4.83) with a cut-off at 48 years. Body mass index independently affected insulin sensitivity as a continuous variable. The prevalence of DM or prediabetes on kidney transplant waiting list is as high as 55%, with more than one third of patients previously undiagnosed. Oral glucose tolerance test is mandatory to detect all patients at risk. Metabolic phenotyping allows for differentiation of underlying pathophysiology and provides a basis for early individual risk stratification and specific intervention to improve patient and allograft outcome.Keywords
This publication has 51 references indexed in Scilit:
- Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes StudyThe Lancet, 2012
- Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimusEuropean Journal of Clinical Pharmacology, 2012
- Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal TransplantationJournal of the American Society of Nephrology, 2012
- Pretransplant Risk Score for New-Onset Diabetes After Kidney TransplantationDiabetes Care, 2011
- Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance TestTransplantation, 2011
- New-Onset Diabetes Mellitus after Kidney Transplantation in DenmarkClinical Journal of the American Society of Nephrology, 2010
- Surrogate markers of insulin resistance: A reviewWorld Journal of Diabetes, 2010
- Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient SurvivalClinical Journal of the American Society of Nephrology, 2008
- Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus TacrolimusAmerican Journal of Transplantation, 2007
- ??-CELL DYSFUNCTION RATHER THAN INSULIN RESISTANCE IS THE MAIN CONTRIBUTING FACTOR FOR THE DEVELOPMENT OF POSTRENAL TRANSPLANTATION DIABETES MELLITUSTransplantation, 2001